Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working GroupMeletios Α. Dimopoulos, Evangelos Terpos, Efstathios Kastritis et al.|The Lancet Oncology|2023Cited by 120
IgM myeloma: A multicenter retrospective study of 134 patientsJorge J. Castillo, Morie A. Gertz, Artur Jurczyszyn et al.|American Journal of Hematology|2017Cited by 49
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patientsSara Rossi, Giuseppe Campiani, Vanessa Tatangelo et al.|Biomedicine & Pharmacotherapy|2024Cited by 9